36
Participants
Start Date
September 15, 2021
Primary Completion Date
November 1, 2025
Study Completion Date
November 1, 2025
Choice Architecture
"1. Providers will receive general training on TPT benefits, indications, and contra-indications.~2. Providers will be provided with updated ART and TPT prescribing approach, including an ink stamp or pre-printed sticker for quick entry of the ART prescription along with TPT and cotrimoxazole.~3. The pharmacy or clinician (if the clinician dispenses) will dispense ART, cotrimoxazole, and TPT as prescribed"
RECRUITING
Perinatal HIV Research Unit, Soweto
University of Witwatersrand, South Africa
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Johns Hopkins University
OTHER